Global Supraglottic Airway Devices Market Size By Type (Laryngeal Mask Airways, Oropharyngeal Airways), By Application (Operating Rooms, Emergency Care Department), By Region, And Segment Forecasts, 2...

The Global Supraglottic Airway Devices Market was valued at USD 1.4 billion in 2023 and is projected to surpass USD 2.6 billion by 2031, growing at a CAGR of 8.3% during the forecast period of 2023–2031. This growth is fueled by the increasing number of surgeries, rising prevalence of respiratory and chronic obstructive pulmonary diseases (COPD), and growing demand for emergency care services. Supraglottic airway devices (SADs) offer a less invasive alternative to tracheal intubation and are extensively used in pre-hospital, surgical, and emergency settings due to their ease of use, rapid placement, and reduced risk of airway trauma.

Drivers:

Increasing Surgical Procedures:

The global rise in elective and emergency surgeries across diverse medical fields is driving demand for effective and safe airway management solutions, such as SADs. These devices are particularly favored in short-duration and ambulatory surgeries.

Rise in Respiratory Disorders:

The escalating prevalence of conditions like sleep apnea and COPD is necessitating effective airway solutions, contributing to the expanding utilization of SADs in clinical and homecare environments.

Growing Geriatric Population:

Aging demographics are more susceptible to airway complications, driving demand for SADs that ensure secure and efficient ventilation, especially during surgical interventions and emergency care.

Restraints:

Risk of Aspiration:

Despite their benefits, SADs carry a higher risk of aspiration compared to endotracheal tubes, especially in patients with full stomachs or those requiring high airway pressures, limiting their use in certain scenarios.

Lack of Skilled Professionals in Low-Income Regions:

The usage of SADs requires trained professionals, and the shortage of skilled healthcare providers in underdeveloped regions hampers market growth.

Opportunity:

Innovation in Device Design:

Advancements in biomaterials and the design of second- and third-generation SADs with improved sealing, safety, and ventilation capabilities are offering significant market expansion opportunities.

Rising Demand from Ambulatory Surgical Centers (ASCs):

The increase in outpatient surgical procedures at ASCs globally provides a growing market for cost-effective and easily deployable airway management devices.

Market by System Type Insights:

The Second-Generation Supraglottic Airway Devices segment held the largest market share in 2023 due to their enhanced safety features, including gastric drainage channels and improved oropharyngeal seal pressures. These devices are preferred for both routine surgeries and difficult airway scenarios. The Third-Generation Devices segment is anticipated to experience the fastest growth owing to innovations focused on integrating video guidance and real-time monitoring.

Market by End-use Insights:

Hospitals emerged as the leading end-use segment in 2023, accounting for over 55% of the global market share, driven by the high volume of surgical procedures and access to advanced medical infrastructure. However, the Ambulatory Surgical Centers segment is projected to witness the highest growth rate due to cost-efficiency, faster patient turnover, and increasing surgical case volumes in outpatient settings.

Market by Regional Insights:

North America dominated the market in 2023, primarily due to the presence of key market players, favorable reimbursement frameworks, and high adoption of advanced medical technologies. Asia-Pacific is projected to grow at the highest CAGR through 2031, supported by improving healthcare infrastructure, rising healthcare expenditure, and increasing awareness about modern airway management practices in countries such as China and India.

Competitive Scenario:

Prominent players in the Global Supraglottic Airway Devices Market include Medtronic plc, Teleflex Incorporated, Ambu A/S, Intersurgical Ltd., Vyaire Medical Inc., Smiths Medical, SunMed, and Legend Medical Devices, Inc. These companies are focusing on product innovation, portfolio expansion, and mergers & acquisitions to solidify their market presence.

Key Developments:

2023: Ambu A/S introduced its single-use third-generation laryngeal mask designed for use with fiber-optic visualization in difficult airway management.

2024: Teleflex Incorporated launched an advanced SAD with integrated CO2 monitoring for enhanced safety in anesthesia care.

2025: Medtronic partnered with a leading AI healthtech firm to incorporate real-time monitoring solutions into its airway management portfolio.

Scope of Work – Global Supraglottic Airway Devices Market

Report Metric Details

Market Size (2023) USD 1.4 billion

Projected Market Size (2031) USD 2.6 billion

CAGR (2023–2031) 8.3%

Market Segments By System Type (1st Gen, 2nd Gen, 3rd Gen), By End-use (Hospitals, ASCs)

Growth Drivers Rise in surgeries, prevalence of respiratory disorders, elderly population

Opportunities Innovations in design, growth of ASCs

FAQs

What is the current market size of the Global Supraglottic Airway Devices Market?

The market size was valued at USD 1.4 billion in 2023.

What is the major growth driver of the Global Supraglottic Airway Devices Market?

The primary driver is the increasing number of surgical procedures and the rising prevalence of respiratory diseases.

Which is the largest region during the forecast p